Published 5 hours ago • loading... • Updated 5 hours agoShow Less Icon‘Selling and marketing snake oil’: The debate over compounded GLP-1s Summary by healthcaredive.comProponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort Iconhealthcaredive.comCenterFactualityOwnership‘Selling and marketing snake oil’: The debate over compounded GLP-1sProponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.5 hours agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated5 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to Vantagehealthcaredive.com broke the news 5 hours ago on Tuesday, November 17, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsGLP-1 Plus IconUnited States Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsGLP-1 Plus IconUnited States Plus IconShow All